HR Execs on the Move

Halyard Health

www.halyardhealth.com

 
Halyard Health is a medical technology company focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. We deliver clinically-superior products and solutions in infection prevention, surgical solutions, respiratory health, digestive health, pain management and IV therapy. Halyard Health became an independent company headquartered in Alpharetta, Georgia on November 1, 2014. Halyard operates 12 global manufacturing facilities with 16,500 employees worldwide – generating approximately $1.7 billion in net revenues. Halyard Health is traded on the New York Stock Exchange under the ticker symbol “HYH”.
  • Number of Employees: 5K-10K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details

Similar Companies

Montvale Technologies

Montvale Technologies is a Montvale, NJ-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

AandM Instruments Inc

A&M Instruments Inc is a Alpharetta, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

StimGuard

StimGuard is a privately held medical device company engaged in the development, manufacture, and pre-commercialization of wirelessly powered, microtechnology neurostimulators, providing patients with a convenient, safe, minimally invasive, and highly cost-effective urological solution that is easily incorporated into their daily lives. StimGuard`s goal is to evolve its patented, cutting-edge platform into the default for neuromodulation, increasing the accessibility for patients worldwide while lowering the economic impact of urology care management.

Futuremed America Inc

Futuremed America Inc is a Granada Hills, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Silk Road Medical

Silk Road Medical, Inc. is a medical device company located in Sunnyvale, California, that is focused on reducing the risk of stroke and its devastating impact. The company has pioneered a new approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The TransCarotid Artery Revascularization (TCAR) Procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. The ENROUTE® Transcarotid Neuroprotection and Stent System are the first and only products specifically designed and indicated for TCAR in high surgical risk patients that need carotid intervention.